
SCWorx Corp. WORX
$ 0.19
-2.4%
Quarterly report 2025-Q3
added 11-12-2025
SCWorx Corp. DSO Ratio 2011-2025 | WORX
Annual DSO Ratio SCWorx Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.4 | 30.7 | 36.2 | 46.8 | 50.6 | 52.6 | 78.3 | 19.5 | 5.21 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 78.3 | 5.21 | 40.1 |
Quarterly DSO Ratio SCWorx Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.2 | 39.3 | 34.7 | - | 67.2 | 59.2 | 39.1 | - | 39.4 | 37 | 31.1 | - | 24.7 | 46 | 51.4 | - | 33.1 | 63.1 | 69.3 | - | 56.2 | 45.6 | 61.8 | - | 43.4 | 53.4 | 48.2 | - | 48.7 | 58.5 | 30.2 | - | 133 | 43.7 | 14.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 133 | 14.2 | 49.5 |
DSO Ratio of other stocks in the Health information services industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Covetrus
CVET
|
39.4 | - | - | $ 2.94 B | ||
|
Cerner Corporation
CERN
|
73.8 | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
59.7 | - | 4.4 % | $ 133 M | ||
|
Accolade
ACCD
|
9.76 | - | 0.29 % | $ 206 M | ||
|
Castlight Health, Inc.
CSLT
|
79 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
144 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
94.4 | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
127 | - | - | $ 102 M | ||
|
Change Healthcare
CHNG
|
87 | - | - | $ 9.03 B | ||
|
Evolent Health
EVH
|
210 | $ 3.95 | -2.47 % | $ 370 M | ||
|
Health Catalyst
HCAT
|
69.9 | $ 2.37 | -0.42 % | $ 143 M | ||
|
HealthStream
HSTM
|
40.4 | $ 23.18 | -0.39 % | $ 704 M | ||
|
MTBC
MTBC
|
40.6 | - | -0.58 % | $ 51.7 M | ||
|
Akerna Corp.
KERN
|
7.62 | - | - | $ 161 M | ||
|
HealthEquity
HQY
|
140 | $ 91.96 | -0.58 % | $ 7.87 B | ||
|
Progyny
PGNY
|
292 | $ 25.85 | 0.04 % | $ 2.22 B | ||
|
So-Young International
SY
|
-6.34 K | $ 2.55 | 0.99 % | $ 202 M | ||
|
American Well Corporation
AMWL
|
90.4 | $ 4.85 | 1.04 % | $ 72.7 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
81.9 | - | -10.39 % | $ 886 M | ||
|
OptimizeRx Corporation
OPRX
|
149 | $ 12.37 | -0.2 % | $ 212 M | ||
|
10x Genomics
TXG
|
64.6 | $ 16.3 | 0.03 % | $ 1.91 B | ||
|
Schrödinger
SDGR
|
265 | $ 17.81 | 0.03 % | $ 1.29 B | ||
|
GoodRx Holdings
GDRX
|
66.7 | $ 2.73 | 1.49 % | $ 1.05 B | ||
|
Omnicell
OMCL
|
83.4 | $ 45.62 | -0.65 % | $ 2.1 B | ||
|
1Life Healthcare
ONEM
|
50.2 | - | - | $ 3.37 B | ||
|
Phreesia
PHR
|
59.5 | $ 16.92 | -0.65 % | $ 923 M | ||
|
Premier
PINC
|
139 | $ 28.26 | - | $ 2.33 B | ||
|
R1 RCM
RCM
|
27.5 | - | - | $ 3.81 B | ||
|
NantHealth
NH
|
32 | - | -46.64 % | $ 10.4 M | ||
|
NextGen Healthcare
NXGN
|
51.6 | - | - | $ 1.6 B | ||
|
Zhongchao
ZCMD
|
116 | $ 0.46 | -25.42 % | $ 2.39 M | ||
|
Signify Health
SGFY
|
272 | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | ||
|
Teladoc Health
TDOC
|
30.7 | $ 6.96 | -0.43 % | $ 1.19 B | ||
|
Tabula Rasa HealthCare
TRHC
|
24.8 | - | - | $ 255 M | ||
|
Veeva Systems
VEEV
|
120 | $ 224.89 | 0.11 % | $ 36.1 B |